Inflammatory Signalings Involved in Airway and Pulmonary Diseases

In respiratory diseases, there is an increased expression of multiple inflammatory proteins in the respiratory tract, including cytokines, chemokines, and adhesion molecules. Chemokines have been shown to regulate inflammation and immune cell differentiation. Moreover, many of the known inflammatory...

Full description

Saved in:
Bibliographic Details
Main Authors: I-Ta Lee, Chuen-Mao Yang
Format: Article
Language:English
Published: Wiley 2013-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1155/2013/791231
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832552330624499712
author I-Ta Lee
Chuen-Mao Yang
author_facet I-Ta Lee
Chuen-Mao Yang
author_sort I-Ta Lee
collection DOAJ
description In respiratory diseases, there is an increased expression of multiple inflammatory proteins in the respiratory tract, including cytokines, chemokines, and adhesion molecules. Chemokines have been shown to regulate inflammation and immune cell differentiation. Moreover, many of the known inflammatory target proteins, such as matrix metalloproteinase-9 (MMP-9), intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1), cyclooxygenase-2 (COX-2), and cytosolic phospholipase A2 (cPLA2), are associated with airway and lung inflammation in response to various stimuli. Injuriously environmental stimuli can access the lung through either the airways or the pulmonary and systemic circulations. The time course and intensity of responses by resident and circulating cells may be regulated by various inflammatory signalings, including Src family kinases (SFKs), protein kinase C (PKC), growth factor tyrosine kinase receptors, nicotinamide adenine dinucleotide phosphate (NADPH)/reactive oxygen species (ROS), PI3K/Akt, MAPKs, nuclear factor-kappa B (NF-κB), activator protein-1 (AP-1), and other signaling molecules. These signaling molecules regulate both key inflammatory signaling transduction pathways and target proteins involved in airway and lung inflammation. Here, we discuss the mechanisms involved in the expression of inflammatory target proteins associated with the respiratory diseases. Knowledge of the mechanisms of inflammation regulation could lead to the pharmacological manipulation of anti-inflammatory drugs in the respiratory diseases.
format Article
id doaj-art-e0c0425983914486959197fe1a42e1e6
institution Kabale University
issn 0962-9351
1466-1861
language English
publishDate 2013-01-01
publisher Wiley
record_format Article
series Mediators of Inflammation
spelling doaj-art-e0c0425983914486959197fe1a42e1e62025-02-03T05:59:05ZengWileyMediators of Inflammation0962-93511466-18612013-01-01201310.1155/2013/791231791231Inflammatory Signalings Involved in Airway and Pulmonary DiseasesI-Ta Lee0Chuen-Mao Yang1Department of Anesthetics, Chang Gung Memorial Hospital at Linkuo and Chang Gung University, Kwei-San, Tao-Yuan 33302, TaiwanDepartment of Physiology and Pharmacology and Health Aging Research Center, College of Medicine, Chang Gung University Kwei-San, Tao-Yuan 33302, TaiwanIn respiratory diseases, there is an increased expression of multiple inflammatory proteins in the respiratory tract, including cytokines, chemokines, and adhesion molecules. Chemokines have been shown to regulate inflammation and immune cell differentiation. Moreover, many of the known inflammatory target proteins, such as matrix metalloproteinase-9 (MMP-9), intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1), cyclooxygenase-2 (COX-2), and cytosolic phospholipase A2 (cPLA2), are associated with airway and lung inflammation in response to various stimuli. Injuriously environmental stimuli can access the lung through either the airways or the pulmonary and systemic circulations. The time course and intensity of responses by resident and circulating cells may be regulated by various inflammatory signalings, including Src family kinases (SFKs), protein kinase C (PKC), growth factor tyrosine kinase receptors, nicotinamide adenine dinucleotide phosphate (NADPH)/reactive oxygen species (ROS), PI3K/Akt, MAPKs, nuclear factor-kappa B (NF-κB), activator protein-1 (AP-1), and other signaling molecules. These signaling molecules regulate both key inflammatory signaling transduction pathways and target proteins involved in airway and lung inflammation. Here, we discuss the mechanisms involved in the expression of inflammatory target proteins associated with the respiratory diseases. Knowledge of the mechanisms of inflammation regulation could lead to the pharmacological manipulation of anti-inflammatory drugs in the respiratory diseases.http://dx.doi.org/10.1155/2013/791231
spellingShingle I-Ta Lee
Chuen-Mao Yang
Inflammatory Signalings Involved in Airway and Pulmonary Diseases
Mediators of Inflammation
title Inflammatory Signalings Involved in Airway and Pulmonary Diseases
title_full Inflammatory Signalings Involved in Airway and Pulmonary Diseases
title_fullStr Inflammatory Signalings Involved in Airway and Pulmonary Diseases
title_full_unstemmed Inflammatory Signalings Involved in Airway and Pulmonary Diseases
title_short Inflammatory Signalings Involved in Airway and Pulmonary Diseases
title_sort inflammatory signalings involved in airway and pulmonary diseases
url http://dx.doi.org/10.1155/2013/791231
work_keys_str_mv AT italee inflammatorysignalingsinvolvedinairwayandpulmonarydiseases
AT chuenmaoyang inflammatorysignalingsinvolvedinairwayandpulmonarydiseases